Loading organizations...
Financière Arbevel is an independent asset management firm based in Paris, France, that invests across equities, private equity, private debt, and bonds with a focus on small and mid-cap companies. The firm provides private wealth management and financing solutions, specializing in active research-driven investment analysis within the technology, biotechnology, and financial sectors for institutional and private investors. Prior to its recent consolidation, the company managed approximately €1.07 billion in total assets. In January 2025, the firm merged with Montpensier Finance to create a combined entity that manages over €6 billion in assets under management and employs more than 80 people. The organization operates alongside notable financial partners and stakeholders, including Amundi and Weinberg Capital Partners, which acquired a stake to facilitate the recent strategic merger. Financière Arbevel was founded in 2012 by Emmanuel Debuyck.
Financière Arbevel has 3 tracked investments across 3 companies. The latest tracked deal is $15.2M Series C in keepMED in September 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 29, 2020 | keepMED | $15.2M Series C | — | 4See Ventures, C4 Ventures, Celeste Management, Lavorel Medicare, Valerie Calenda, Pitango Venture Capital, Xenia Venture Capital |
| Feb 1, 2020 | Scipio Bioscience | $7.0M Series A | Arnaud Autret | Seventure Partners, High Tech Grunderfonds, Verve Ventures |
| Sep 10, 2019 | Keranova | $26.5M Other Equity | — | Valerie Calenda, Supernova Invest, Philippe Tourrette |